“Neural Precursor Cells II” (Neurale Vorläuferzellen II) View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-11

AUTHORS

Decision of the Federal Supreme Court (Bundesgerichtshof) 27 November 2012 – Case No. X ZR 58/07

ABSTRACT

The unrestricted patenting of precursor cells obtained from human embryonic stem cells is excluded pursuant to Sec. 2(2) first sentence No. 3 of the Patent Act if the patent specification states that stem cell lines and stem cells obtained from human embryos could be used as starting material.Section 2(2) first sentence No. 3 of the Patent Act does not prevent patenting in the said constellation if the patent claim is restricted to the effect that precursor cells from human embryonic stem cells produced by destruction of embryos are not encompassed.Human stem cells obtained without the destruction of embryos are not to be seen as embryos within the meaning of Sec. 2(2) first sentence No. 3 of the Patent Act merely on the grounds that by combining them with other cells they can possibly be used to generate an embryo capable of development. The unrestricted patenting of precursor cells obtained from human embryonic stem cells is excluded pursuant to Sec. 2(2) first sentence No. 3 of the Patent Act if the patent specification states that stem cell lines and stem cells obtained from human embryos could be used as starting material. Section 2(2) first sentence No. 3 of the Patent Act does not prevent patenting in the said constellation if the patent claim is restricted to the effect that precursor cells from human embryonic stem cells produced by destruction of embryos are not encompassed. Human stem cells obtained without the destruction of embryos are not to be seen as embryos within the meaning of Sec. 2(2) first sentence No. 3 of the Patent Act merely on the grounds that by combining them with other cells they can possibly be used to generate an embryo capable of development. More... »

PAGES

831-836

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s40319-013-0113-7

DOI

http://dx.doi.org/10.1007/s40319-013-0113-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1005843728


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1004", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Biotechnology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/10", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Technology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "familyName": "Decision of the Federal Supreme Court (Bundesgerichtshof) 27 November 2012 \u2013 Case No. X ZR 58/07", 
        "type": "Person"
      }
    ], 
    "datePublished": "2013-11", 
    "datePublishedReg": "2013-11-01", 
    "description": "The unrestricted patenting of precursor cells obtained from human embryonic stem cells is excluded pursuant to Sec. 2(2) first sentence No. 3 of the Patent Act if the patent specification states that stem cell lines and stem cells obtained from human embryos could be used as starting material.Section 2(2) first sentence No. 3 of the Patent Act does not prevent patenting in the said constellation if the patent claim is restricted to the effect that precursor cells from human embryonic stem cells produced by destruction of embryos are not encompassed.Human stem cells obtained without the destruction of embryos are not to be seen as embryos within the meaning of Sec. 2(2) first sentence No. 3 of the Patent Act merely on the grounds that by combining them with other cells they can possibly be used to generate an embryo capable of development. The unrestricted patenting of precursor cells obtained from human embryonic stem cells is excluded pursuant to Sec. 2(2) first sentence No. 3 of the Patent Act if the patent specification states that stem cell lines and stem cells obtained from human embryos could be used as starting material. Section 2(2) first sentence No. 3 of the Patent Act does not prevent patenting in the said constellation if the patent claim is restricted to the effect that precursor cells from human embryonic stem cells produced by destruction of embryos are not encompassed. Human stem cells obtained without the destruction of embryos are not to be seen as embryos within the meaning of Sec. 2(2) first sentence No. 3 of the Patent Act merely on the grounds that by combining them with other cells they can possibly be used to generate an embryo capable of development.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s40319-013-0113-7", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1026584", 
        "issn": [
          "0018-9855", 
          "2195-0237"
        ], 
        "name": "IIC - International Review of Intellectual Property and Competition Law", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "44"
      }
    ], 
    "name": "\u201cNeural Precursor Cells II\u201d (Neurale Vorl\u00e4uferzellen II)", 
    "pagination": "831-836", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1bd70fbb3991a64eb18abcb38266cde6a62dd71411a28bc1176f2a2cf5301eaa"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40319-013-0113-7"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1005843728"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40319-013-0113-7", 
      "https://app.dimensions.ai/details/publication/pub.1005843728"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000520.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs40319-013-0113-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40319-013-0113-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40319-013-0113-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40319-013-0113-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40319-013-0113-7'


 

This table displays all metadata directly associated to this object as RDF triples.

55 TRIPLES      20 PREDICATES      27 URIs      19 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s40319-013-0113-7 schema:about anzsrc-for:10
2 anzsrc-for:1004
3 schema:author Nb3aef7c39a544a3ebbbea74f0790122c
4 schema:datePublished 2013-11
5 schema:datePublishedReg 2013-11-01
6 schema:description The unrestricted patenting of precursor cells obtained from human embryonic stem cells is excluded pursuant to Sec. 2(2) first sentence No. 3 of the Patent Act if the patent specification states that stem cell lines and stem cells obtained from human embryos could be used as starting material.Section 2(2) first sentence No. 3 of the Patent Act does not prevent patenting in the said constellation if the patent claim is restricted to the effect that precursor cells from human embryonic stem cells produced by destruction of embryos are not encompassed.Human stem cells obtained without the destruction of embryos are not to be seen as embryos within the meaning of Sec. 2(2) first sentence No. 3 of the Patent Act merely on the grounds that by combining them with other cells they can possibly be used to generate an embryo capable of development. The unrestricted patenting of precursor cells obtained from human embryonic stem cells is excluded pursuant to Sec. 2(2) first sentence No. 3 of the Patent Act if the patent specification states that stem cell lines and stem cells obtained from human embryos could be used as starting material. Section 2(2) first sentence No. 3 of the Patent Act does not prevent patenting in the said constellation if the patent claim is restricted to the effect that precursor cells from human embryonic stem cells produced by destruction of embryos are not encompassed. Human stem cells obtained without the destruction of embryos are not to be seen as embryos within the meaning of Sec. 2(2) first sentence No. 3 of the Patent Act merely on the grounds that by combining them with other cells they can possibly be used to generate an embryo capable of development.
7 schema:genre research_article
8 schema:inLanguage en
9 schema:isAccessibleForFree false
10 schema:isPartOf N0765426e38bf4cd5b26f8cab69397ad5
11 N810258e48b504342ae758be22063b5b3
12 sg:journal.1026584
13 schema:name “Neural Precursor Cells II” (Neurale Vorläuferzellen II)
14 schema:pagination 831-836
15 schema:productId N7868ed7669544a11b7673a61828958b4
16 Nd1c9c1f9d62b469293964ed0739a0e79
17 Nf576958e64cf455fa64e48f5c99d99d2
18 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005843728
19 https://doi.org/10.1007/s40319-013-0113-7
20 schema:sdDatePublished 2019-04-10T15:03
21 schema:sdLicense https://scigraph.springernature.com/explorer/license/
22 schema:sdPublisher Nb44f7386224147fda616dd73629d7419
23 schema:url http://link.springer.com/10.1007%2Fs40319-013-0113-7
24 sgo:license sg:explorer/license/
25 sgo:sdDataset articles
26 rdf:type schema:ScholarlyArticle
27 N0765426e38bf4cd5b26f8cab69397ad5 schema:issueNumber 7
28 rdf:type schema:PublicationIssue
29 N2afe6959229f43d0b6fe565b0294f03a schema:familyName Decision of the Federal Supreme Court (Bundesgerichtshof) 27 November 2012 – Case No. X ZR 58/07
30 rdf:type schema:Person
31 N7868ed7669544a11b7673a61828958b4 schema:name dimensions_id
32 schema:value pub.1005843728
33 rdf:type schema:PropertyValue
34 N810258e48b504342ae758be22063b5b3 schema:volumeNumber 44
35 rdf:type schema:PublicationVolume
36 Nb3aef7c39a544a3ebbbea74f0790122c rdf:first N2afe6959229f43d0b6fe565b0294f03a
37 rdf:rest rdf:nil
38 Nb44f7386224147fda616dd73629d7419 schema:name Springer Nature - SN SciGraph project
39 rdf:type schema:Organization
40 Nd1c9c1f9d62b469293964ed0739a0e79 schema:name doi
41 schema:value 10.1007/s40319-013-0113-7
42 rdf:type schema:PropertyValue
43 Nf576958e64cf455fa64e48f5c99d99d2 schema:name readcube_id
44 schema:value 1bd70fbb3991a64eb18abcb38266cde6a62dd71411a28bc1176f2a2cf5301eaa
45 rdf:type schema:PropertyValue
46 anzsrc-for:10 schema:inDefinedTermSet anzsrc-for:
47 schema:name Technology
48 rdf:type schema:DefinedTerm
49 anzsrc-for:1004 schema:inDefinedTermSet anzsrc-for:
50 schema:name Medical Biotechnology
51 rdf:type schema:DefinedTerm
52 sg:journal.1026584 schema:issn 0018-9855
53 2195-0237
54 schema:name IIC - International Review of Intellectual Property and Competition Law
55 rdf:type schema:Periodical
 




Preview window. Press ESC to close (or click here)


...